JP2016511822A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511822A5
JP2016511822A5 JP2015552068A JP2015552068A JP2016511822A5 JP 2016511822 A5 JP2016511822 A5 JP 2016511822A5 JP 2015552068 A JP2015552068 A JP 2015552068A JP 2015552068 A JP2015552068 A JP 2015552068A JP 2016511822 A5 JP2016511822 A5 JP 2016511822A5
Authority
JP
Japan
Prior art keywords
astrin
cell
raptor
binding fragment
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015552068A
Other languages
English (en)
Japanese (ja)
Other versions
JP6494112B2 (ja
JP2016511822A (ja
Filing date
Publication date
Priority claimed from EP13151022.4A external-priority patent/EP2755027B1/en
Application filed filed Critical
Publication of JP2016511822A publication Critical patent/JP2016511822A/ja
Publication of JP2016511822A5 publication Critical patent/JP2016511822A5/ja
Application granted granted Critical
Publication of JP6494112B2 publication Critical patent/JP6494112B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015552068A 2013-01-11 2014-01-13 アストリンとラプターの相互作用調節因子、及びその癌治療での用途 Expired - Fee Related JP6494112B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13151022.4 2013-01-11
EP13151022.4A EP2755027B1 (en) 2013-01-11 2013-01-11 Modulators of the interaction of astrin and raptor, and uses thereof in cancer therapy
PCT/EP2014/050460 WO2014108532A1 (en) 2013-01-11 2014-01-13 Modulators of the interaction of astrin and raptor, and uses thereof in cancer therapy

Publications (3)

Publication Number Publication Date
JP2016511822A JP2016511822A (ja) 2016-04-21
JP2016511822A5 true JP2016511822A5 (cg-RX-API-DMAC10.html) 2017-02-23
JP6494112B2 JP6494112B2 (ja) 2019-04-03

Family

ID=47563201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015552068A Expired - Fee Related JP6494112B2 (ja) 2013-01-11 2014-01-13 アストリンとラプターの相互作用調節因子、及びその癌治療での用途

Country Status (5)

Country Link
US (1) US10041933B2 (cg-RX-API-DMAC10.html)
EP (1) EP2755027B1 (cg-RX-API-DMAC10.html)
JP (1) JP6494112B2 (cg-RX-API-DMAC10.html)
ES (1) ES2588778T3 (cg-RX-API-DMAC10.html)
WO (1) WO2014108532A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11237168B2 (en) * 2019-06-26 2022-02-01 St. Jude Children's Research Hospital Method for identifying modulators of G3BP activity
CN110476877A (zh) * 2019-08-15 2019-11-22 上海交通大学医学院附属瑞金医院 一种β细胞中特异性Raptor敲除同时GFP示踪的小鼠的制备方法
CN113125747B (zh) * 2021-03-15 2022-06-14 天津医科大学 一种isPLA-Seq的高通量检测蛋白质相互作用的方法和试剂盒及其应用

Similar Documents

Publication Publication Date Title
Dewidar et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis—updated 2019
Khalil et al. Emerging therapeutic approaches to target the dark side of senescent cells: new hopes to treat aging as a disease and to delay age-related pathologies
Gao et al. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
Martinez-Outschoorn et al. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4
EA201890796A1 (ru) Новое антитело к мезотелину и содержащая его композиция
Song et al. Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
WO2013182912A3 (en) Method for the diagnosis, prognosis and treatment of lung cancer metastasis
EA201892774A1 (ru) Антитела
MX2021014952A (es) Molecula de union especifica para cd73 y uso de la molecula de union.
WO2014140933A3 (en) Method for the prognosis and treatment of cancer metastasis
WO2014057357A3 (en) Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
BR112017010110A2 (pt) anticorpos contra cd73 e usos do mesmo
EP4032544A3 (en) Novel t cell receptors and immune therapy using the same
BR112012020373A8 (pt) anticorpo isolado, célula, ácido nucleico isolado, método de identificação, de inibição da proliferação de uma célula, de tratamento terapêutico, de determinação da presença de uma proteína tat419, de diagnóstico da presença de câncer e de distribuição de agente citotóxico
Al-Greene et al. Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma
AR085955A1 (es) Proteinas de union al antigeno
EA201690503A1 (ru) Антитела
BR112012019459A2 (pt) identificação de mutação de lkb1 como um biomarcador preditivo para sensibilidade para inibidores de tor quinase.
MX2017004729A (es) Terapia de combinacion para usar en la terapia contra el cancer.
WO2011133609A3 (en) Methods and kits to predict therapeutic outcome of btk inhibitors
Cai et al. Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
WO2015052583A3 (en) Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer
WO2017217807A3 (ko) Nckap1을 유효성분으로 포함하는 대장암 진단 또는 대장암 전이 예후 예측용 바이오마커 조성물
NZ609567A (en) Markers of endothelial progenitor cells and uses thereof